Treace Medical Concepts, Inc.

NasdaqGS:TMCI Rapporto sulle azioni

Cap. di mercato: US$483.4m

Treace Medical Concepts Gestione

Gestione criteri di controllo 2/4

Treace Medical Concepts Il CEO è John Treace, nominato in Jul2014, e ha un mandato di 10.33 anni. la retribuzione annua totale è $ 8.42M, composta da 8.1% di stipendio e 91.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 18.7% delle azioni della società, per un valore di $ 90.41M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.2 anni e 6.8 anni.

Informazioni chiave

John Treace

Amministratore delegato

US$8.4m

Compenso totale

Percentuale dello stipendio del CEO8.1%
Mandato del CEO10.3yrs
Proprietà del CEO18.7%
Durata media del management3.2yrs
Durata media del Consiglio di amministrazione6.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way?

Oct 26
Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way?

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch

Aug 02
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch

Treace Medical Concepts (NASDAQ:TMCI) Has Debt But No Earnings; Should You Worry?

Jun 28
Treace Medical Concepts (NASDAQ:TMCI) Has Debt But No Earnings; Should You Worry?

Treace Medical Concepts: Facing Increasing Competitive Pressure

Jun 14

Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Apr 05
Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)

Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Feb 09
Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Jan 04
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge

Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Nov 11
Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower

Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

Aug 13
Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di John Treace rispetto agli utili di Treace Medical Concepts?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$62m

Jun 30 2024n/an/a

-US$64m

Mar 31 2024n/an/a

-US$55m

Dec 31 2023US$8mUS$684k

-US$50m

Sep 30 2023n/an/a

-US$48m

Jun 30 2023n/an/a

-US$42m

Mar 31 2023n/an/a

-US$47m

Dec 31 2022US$4mUS$568k

-US$43m

Sep 30 2022n/an/a

-US$45m

Jun 30 2022n/an/a

-US$39m

Mar 31 2022n/an/a

-US$27m

Dec 31 2021US$688kUS$410k

-US$21m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$5m

Dec 31 2020US$392kUS$316k

-US$4m

Compensazione vs Mercato: La retribuzione totale di John ($USD 8.42M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 2.16M ).

Compensazione vs guadagni: La retribuzione di John è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

John Treace (52 yo)

10.3yrs

Mandato

US$8,422,635

Compensazione

Mr. John T. Treace Founded Treace Medical Concepts, Inc. in 2014 and has been its Chief Executive Officer and Director since July 1, 2014. Before that, Mr. Treace served as Senior Vice President of U.S. Sa...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
John Treace
CEO, Founder & Director10.3yrsUS$8.42m18.7%
$ 90.4m
Mark Hair
Chief Financial Officer4.2yrsUS$4.69m0.031%
$ 150.2k
Aaron Berutti
Senior Vice President of Sales3.3yrsUS$3.26m0.0066%
$ 31.7k
Terry Lubben
Chief Operations & Supply Chain Officer3.2yrsNessun datoNessun dato
Taylor Erickson
Chief Information Officer2.7yrsNessun datoNessun dato
Scot Elder
Chief Legal & Compliance Officer and Corporate Secretary3.1yrsNessun dato0.050%
$ 240.4k
Nathan Minnich
Senior Vice President of Marketing1.3yrsNessun datoNessun dato
Daniel Owens
Chief Human Resources Officer3.8yrsNessun dato0.0084%
$ 40.8k
Sean Scanlan
Chief Innovation Officer1.8yrsNessun dato0.056%
$ 270.7k
Shana Zink
Senior Vice President of Clinical Affairs & Reimbursementno dataNessun datoNessun dato
Rachel Osbeck
Senior Vice President of Quality Assurance & Regulatory Affairsno dataNessun datoNessun dato

3.2yrs

Durata media

52yo

Età media

Gestione esperta: Il team dirigenziale di TMCI è considerato esperto (durata media dell'incarico 3.2 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
John Treace
CEO, Founder & Director10.3yrsUS$8.42m18.7%
$ 90.4m
Lawrence Hamilton
Independent Director4yrsUS$214.79k0.0081%
$ 39.2k
James Treace
Chairman of the Board10.4yrsUS$94.74k2.86%
$ 13.8m
Richard Mott
Independent Director9.7yrsUS$197.26k1.7%
$ 8.2m
John Bakewell
Independent Director4yrsUS$214.79k0.77%
$ 3.7m
Deepti Jain
Independent Director3.1yrsUS$209.79k0.050%
$ 239.3k
Paul Dayton
Member of the Surgeon Advisory Boardno dataNessun datoNessun dato
William DeCarbo
Member of the Surgeon Advisory Boardno dataNessun datoNessun dato
Daniel Hatch
Member of the Surgeon Advisory Boardno dataNessun datoNessun dato
J.P. McAleer
Member of the Surgeon Advisory Boardno dataNessun datoNessun dato
W. Smith
Member of the Surgeon Advisory Boardno dataNessun datoNessun dato
Robert Santrock
Member of the Surgeon Advisory Boardno dataNessun datoNessun dato

6.8yrs

Durata media

63.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di TMCI sono considerati esperti (durata media dell'incarico 6.8 anni).